And it's not too late to get in on the action.

On April 1, Eli Lilly (NYSE: LLY) and its shareholders received the news they were eagerly awaiting: the approval of the company's GLP-1 pill, Foundayo. While the company isn't the first out of the ...

Lilly Pulitzer is known for rarely offering discounts on its highly sought-after apparel, but the brand is now kicking off ...

Amazon will offer delivery of Eli Lilly's new weight-loss pill Foundayo and stock it at kiosks at some of the company's ...

The daily pill, called Foundayo, could make it easier for more people to lose weight.

Eli Lilly and Company (NYSE:LLY | LLY Price Prediction) and Novo Nordisk A/S (NYSE:NVO) reported quarterly results in early ...

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.

By Amina Niasse NEW YORK, April 9 (Reuters) - Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight ...

Eli Lilly & Co. agreed to buy sleep drug maker Centessa Pharmaceuticals Plc in a deal worth up to $7.8 billion, a sign the ...

Eli Lilly has rolled out Foundayo, its oral GLP-1 pill, directly to consumers through its LillyDirect cash-pay channel, as ...

Eli Lilly has handed AC Immune 10 million Swiss francs ($12.5 million) to expand their Alzheimer’s disease collaboration as a candidate moves closer to the clinic. The U.S. pharma first tapped up AC ...

Eli Lilly ( LLY 0.47%) has not performed well this year, with its shares down 13% to date. However, the company's stock ...